Physicians and surgeons struggle to access effective minimally invasive treatment options for deep tissue conditions

Medical professionals face limited options for treating deep tissue pathologies (fibrosis, adipose tissue, etc.) without invasive surgery, leading to longer patient recovery times and higher complication rates. Current surgical approaches are traumatic and carry significant morbidity, while existing non-invasive technologies lack the precision and depth penetration needed for effective treatment. Profound Medical's earnings call indicates strong demand for their radiofrequency-based solutions, suggesting this is an urgent clinical gap.